Last Updated：2025/11/28
In recent trials, lestaurtinib showed promising activity against acute myeloid leukemia with FLT3 mutations.
See correct answer
In recent trials, lestaurtinib showed promising activity against acute myeloid leukemia with FLT3 mutations.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
